AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
91.43%
Total 13F principal
$291,319,506
Principal change
-$2,019,000
Total reported market value
$266,401,370
Number of holders
28
Value change
-$2,780,250
Number of buys
10
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q4 2018

As of 31 Dec 2018, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 28 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $291,319,506 in principal (par value) of the bond. The largest 10 bondholders included STEELHEAD PARTNERS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CNH PARTNERS LLC, CAMDEN ASSET MANAGEMENT L P /CA, WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, CITADEL ADVISORS LLC, CALAMOS ADVISORS LLC, Context Capital Management, LLC, and City Financial Investment Co Ltd. This page lists 28 institutional bondholders reporting positions for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.